ArticleBiomedicines2024

New Insights into Chemoresistance Mediated by Mdm2 Inhibitors: The Benefits of Targeted Therapy over Common Cytostatics.

Tatyana Grigoreva et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.